Benefits
L-Ergothioneine: what the research actually shows
Ergothioneine is the active in MitoPrime. It performs well in test tube antioxidant assays, but the comparisons with glutathione, vitamin C and CoQ10 come from laboratory chemistry, not from trials comparing them in people. Some researchers have proposed treating it as a conditionally essential nutrient because the body has a specific transporter for it and blood levels fall after about age 60. That is a proposal under discussion in review articles, not an official classification, and no study has compared MitoGreens with any other greens product.
29 fruit, berry and botanical ingredients
Concentrated blend of 29 clean and potent superfood ingredients including blueberry, acerola, bilberry, apple, camu-camu, raspberry, and other fruit/berry extracts. A blend like this supplies a mix of plant compounds, but the combination has not been tested in any published human study, and none of the individual botanicals has been tested at the amount supplied by a 100 mg serving. There is no published comparison with other greens powders, and nothing cited here shows that competing products contain impurities or fillers.
Antioxidant content and what ORAC means
ORAC (Oxygen Radical Absorbance Capacity) measures how a sample soaks up free radicals in a tube. The USDA has withdrawn its ORAC database because those values were not shown to predict effects in the human body, so a high ORAC number is not evidence of a health benefit. None of the studies cited on this page measured free radicals or oxidative stress in people taking MitoGreens.
Quercetin: what the meta-analysis found
Quercetin is one of the listed components. A meta-analysis of randomized human trials of isolated quercetin found it lowered the inflammation marker CRP in people who already had a disease, and lowered IL-6 in women and in the higher dose groups. Those trials used isolated quercetin at research doses, not MitoGreens, and the label does not state how much quercetin a 100 mg serving provides, so there is no way to know whether it comes close. The red blood cell and mitochondrial effects are not supported by any study cited on this page.
Healthy aging support
A 2023 review reported that blood ergothioneine levels tend to decline after age 60, and that people with lower levels showed faster cognitive decline and higher rates of cardiovascular and overall death. Those are observational associations, not proof that taking ergothioneine slows aging, and the review is about ergothioneine rather than MitoGreens. No study has followed people taking this blend over time.
Cognition and immune cells: what is and is not known
The only human trial cited is a pilot in 19 adults aged 60 and over who had already been diagnosed with mild cognitive impairment. Over 12 months, 25 mg of ergothioneine three times a week improved scores on a word learning test and stabilized a blood marker of nerve cell damage compared with placebo, with no safety concerns reported. Nineteen people is far too few to be conclusive, the trial used ergothioneine on its own rather than MitoGreens, and a result in people with a diagnosed condition does not tell a healthy person what to expect. On immunity, ergothioneine is known to concentrate inside immune cells through the OCTN1 transporter, but no cited study measured immune function or infection rates in people.
Concentrated 100 mg per serving
A 100 mg serving is small, which is why brands can add it to powders, drinks, gummies and capsules. For a shopper the trade-off matters: 100 mg split across 29 ingredients plus ergothioneine means each component is present in a very small amount, and the label does not disclose how much of any one of them you get. Check the supplement facts panel of the finished product rather than assuming the amounts match the doses used in research.
Mechanism of action
L-Ergothioneine — mitochondrial protection
Laboratory work shows ergothioneine enters cells through the OCTN1 transporter and concentrates in tissues, including mitochondria, where it can act as an antioxidant. The existence of a dedicated transporter is why some researchers argue the compound has a physiological role. This is a proposed mechanism from cell and animal work. It has not been shown to slow aging in people, and it was never tested using MitoGreens.
Quercetin AMPK and mitochondrial biogenesis
In cell and animal studies, quercetin has been reported to activate AMPK and PGC-1 alpha, signals involved in making new mitochondria. None of the human studies cited on this page measured mitochondria, energy production or metabolic flexibility, and these effects have not been demonstrated at the amount of quercetin contained in a 100 mg serving of this blend.
Polyphenol multi-pathway antioxidant
29 superfood botanicals provide multiple polyphenol classes — flavonoids, anthocyanins, proanthocyanidins, phenolic acids. Different polyphenol classes behave differently in laboratory antioxidant tests. Whether combining them produces a larger effect in the body than a single compound has never been tested for this blend in a published study.
Free radical reduction (cellular + mitochondrial)
Diets high in fruits and vegetables are generally associated with lower markers of oxidative damage, but none of the four studies cited on this page examined whole diets, and no study has shown that a 100 mg concentrate reproduces what eating those foods does.
Immune cell ergothioneine accumulation
Ergothioneine accumulates in immune cells (neutrophils, monocytes, lymphocytes) via the OCTN1 transporter. The high concentration inside these cells has led researchers to suggest a protective role, but that remains a hypothesis from laboratory work. No cited study measured immune function, immune markers or infection rates in people taking ergothioneine or MitoGreens.
Clinical trials
Randomized, double blind, placebo controlled pilot study over 12 months, published in the Journal of Alzheimer's Disease in 2024 (PMID 39544014). It tested pure ergothioneine at 25 mg three times a week, not MitoGreens, and its own authors describe it as a pilot.
19 adults aged 60 and over who had already been diagnosed with mild cognitive impairment.
The ergothioneine group scored better on the Rey Auditory Verbal Learning Test and had more stable neurofilament light chain, a blood marker of nerve cell damage, than the placebo group, and no safety concerns were reported. With only 19 participants this is a preliminary signal, not a demonstrated benefit. It says nothing about what MitoGreens does, nothing about healthy adults, and the schedule used (25 mg three times weekly) is not the same as a 100 mg blend serving.
Two of the four references on this page are review articles on ergothioneine (FEBS Letters 2018, PMID 29851075, and British Journal of Nutrition 2023, PMID 38018890). Reviews summarize other researchers' work; they are not trials, and neither one involved MitoGreens.
Not applicable. These are review articles, not studies with participants.
The 2018 review describes ergothioneine as a diet derived antioxidant with cytoprotective potential worth investigating. The 2023 review reports that blood levels decline after age 60 and that lower levels are associated with faster cognitive decline and higher mortality, and proposes ergothioneine may be a conditionally essential nutrient. Both are calls for more research. No published trial has tested the MitoGreens blend in people for any outcome.
Meta-analysis of randomized human trials of quercetin supplements, published in the International Journal of Food Sciences and Nutrition in 2020 (PMID 31213101). Quercetin is one component of MitoGreens, so this is single ingredient evidence at research doses, not a study of the blend.
Adults in randomized trials of isolated quercetin, including groups who already had a disease.
Quercetin reduced CRP in people who already had a disease, and reduced IL-6 in women and in the higher dose subgroups. The effect was not uniform across all groups. These trials used isolated quercetin at research doses; MitoGreens does not state how much quercetin a serving contains, so the result cannot be assumed to carry over to the blend.